BG33294A3 - Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид - Google Patents

Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид

Info

Publication number
BG33294A3
BG33294A3 BG043323A BG4332379A BG33294A3 BG 33294 A3 BG33294 A3 BG 33294A3 BG 043323 A BG043323 A BG 043323A BG 4332379 A BG4332379 A BG 4332379A BG 33294 A3 BG33294 A3 BG 33294A3
Authority
BG
Bulgaria
Prior art keywords
desacetyl
carboxhydrazide
vlc
obtaining anti
derivatives
Prior art date
Application number
BG043323A
Other languages
Bulgarian (bg)
English (en)
Inventor
George Cullinan
Koert Gerzon
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG33294A3 publication Critical patent/BG33294A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG043323A 1978-04-20 1979-04-20 Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид BG33294A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/899,032 US4166810A (en) 1978-04-20 1978-04-20 Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide

Publications (1)

Publication Number Publication Date
BG33294A3 true BG33294A3 (bg) 1983-01-14

Family

ID=25410402

Family Applications (3)

Application Number Title Priority Date Filing Date
BG043323A BG33294A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG056469A BG33296A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG056470A BG33297A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG056469A BG33296A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG056470A BG33297A3 (bg) 1978-04-20 1979-04-20 Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид

Country Status (32)

Country Link
US (1) US4166810A (enExample)
EP (1) EP0005051B1 (enExample)
JP (1) JPS54141798A (enExample)
AR (1) AR228940A1 (enExample)
AT (1) AT369010B (enExample)
AU (1) AU527109B2 (enExample)
BE (1) BE875652A (enExample)
BG (3) BG33294A3 (enExample)
CA (1) CA1097629A (enExample)
CH (1) CH643269A5 (enExample)
CS (3) CS218585B2 (enExample)
DD (1) DD143075A5 (enExample)
DE (1) DE2964130D1 (enExample)
DK (1) DK147484C (enExample)
EG (1) EG14867A (enExample)
ES (2) ES479753A1 (enExample)
FI (1) FI791286A7 (enExample)
FR (1) FR2423495A1 (enExample)
GB (1) GB2019396B (enExample)
GR (1) GR69987B (enExample)
HU (1) HU181431B (enExample)
IE (1) IE48213B1 (enExample)
IL (1) IL57168A (enExample)
LU (1) LU81166A1 (enExample)
NZ (1) NZ190213A (enExample)
PH (1) PH14163A (enExample)
PL (3) PL119416B1 (enExample)
PT (1) PT69496A (enExample)
RO (3) RO80084A (enExample)
SU (3) SU893135A3 (enExample)
YU (1) YU93179A (enExample)
ZA (1) ZA791856B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322351A (en) * 1980-08-25 1982-03-30 Eli Lilly And Company Antineoplastic 4'-formylamino and 4'-acetylamino VLB, and derivatives thereof
ATE57187T1 (de) * 1983-03-30 1990-10-15 Lilly Industries Ltd Vincaleukoblastin-derivate.
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
US5043336A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide
WO2002085908A1 (en) * 2001-04-24 2002-10-31 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
US7910594B2 (en) * 2002-05-15 2011-03-22 Endocyte, Inc. Vitamin-mitomycin conjugates
NZ541846A (en) 2003-01-27 2008-12-24 Endocyte Inc Vitamin receptor binding drug delivery conjugates
EP1789391B1 (en) 2004-07-23 2017-06-28 Endocyte, Inc. Bivalent linkers and conjugates thereof
US8044200B2 (en) * 2005-03-16 2011-10-25 Endocyte, Inc. Synthesis and purification of pteroic acid and conjugates thereof
WO2007022494A2 (en) * 2005-08-19 2007-02-22 Endocyte, Inc. Multi-drug ligand conjugates
US20080280937A1 (en) * 2005-08-19 2008-11-13 Christopher Paul Leamon Ligand Conjugates of Vinca Alkaloids, Analogs, and Derivatives
US20100087370A1 (en) * 2007-02-14 2010-04-08 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN104127878A (zh) * 2007-03-14 2014-11-05 恩多塞特公司 结合配体连接的微管溶素递药缀合物
WO2009002993A1 (en) * 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
JP2011500835A (ja) * 2007-10-25 2011-01-06 エンドサイト,インコーポレイテッド チューブリシン類および調製プロセス
JP5780961B2 (ja) * 2009-09-07 2015-09-16 ニプロパッチ株式会社 経皮吸収型製剤
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
KR20150070318A (ko) 2012-10-16 2015-06-24 엔도사이트, 인코포레이티드 비천연 아미노산을 함유하는 약물 전달 컨쥬게이트 및 사용 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3205220A (en) * 1961-10-26 1965-09-07 Lilly Co Eli Leurosidine and leurocristine and their production
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US3370057A (en) * 1964-04-27 1968-02-20 Lilly Co Eli Leurosine
US3387001A (en) * 1964-10-19 1968-06-04 Lilly Co Eli Novel aminoacyl esters of desacetyl vincaleukoblastine
US3887565A (en) * 1974-05-06 1975-06-03 Lilly Co Eli Vincadioline
US3890325A (en) * 1974-05-15 1975-06-17 Lilly Co Eli Leurocolombine
US3954773A (en) * 1974-11-21 1976-05-04 Eli Lilly And Company 4-Desacetoxyvinblastine
US3944554A (en) * 1975-01-09 1976-03-16 Eli Lilly And Company 4-Desacetoxy-3-hydroxyvinblastine
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4115388A (en) * 1977-03-30 1978-09-19 Eli Lilly And Company 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds

Also Published As

Publication number Publication date
RO81037B (ro) 1983-01-30
RO81037A (ro) 1983-02-01
IL57168A (en) 1983-10-31
GB2019396B (en) 1982-09-15
FI791286A7 (fi) 1981-01-01
HU181431B (en) 1983-07-28
PL215911A1 (enExample) 1980-03-24
DK147484B (da) 1984-08-27
CS218583B2 (en) 1983-02-25
EP0005051A1 (en) 1979-10-31
IE48213B1 (en) 1984-10-31
IL57168A0 (en) 1979-07-25
ATA291279A (de) 1982-04-15
AT369010B (de) 1982-11-25
LU81166A1 (fr) 1979-09-07
BG33297A3 (bg) 1983-01-14
CH643269A5 (fr) 1984-05-30
PL125470B1 (en) 1983-05-31
PT69496A (en) 1979-05-01
PH14163A (en) 1981-03-19
AR228940A1 (es) 1983-05-13
RO80084A (ro) 1983-02-01
RO80084B (ro) 1983-01-30
GR69987B (enExample) 1982-07-22
FR2423495B1 (enExample) 1983-02-11
RO81114A (ro) 1983-02-01
FR2423495A1 (fr) 1979-11-16
IE790795L (en) 1979-10-20
GB2019396A (en) 1979-10-31
EP0005051B1 (en) 1982-12-01
EG14867A (en) 1986-09-30
BE875652A (fr) 1979-10-18
SU1061698A3 (ru) 1983-12-15
ZA791856B (en) 1980-11-26
ES479754A1 (es) 1980-08-16
AU527109B2 (en) 1983-02-17
AU4609779A (en) 1979-10-25
CS218585B2 (en) 1983-02-25
SU1225490A3 (ru) 1986-04-15
CS218584B2 (en) 1983-02-25
YU93179A (en) 1983-01-21
RO81114B (ro) 1983-01-30
JPS54141798A (en) 1979-11-05
PL119416B1 (en) 1981-12-31
DK160679A (da) 1979-10-21
ES479753A1 (es) 1980-08-16
DK147484C (da) 1985-03-25
SU893135A3 (ru) 1981-12-23
CA1097629A (en) 1981-03-17
JPS6245873B2 (enExample) 1987-09-29
US4166810A (en) 1979-09-04
NZ190213A (en) 1982-12-21
DD143075A5 (de) 1980-07-30
DE2964130D1 (en) 1983-01-05
BG33296A3 (bg) 1983-01-14

Similar Documents

Publication Publication Date Title
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG28708A3 (bg) Метод за получаване на имидазолови производни
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG38333A3 (bg) Метод за получаване на заместени фенилкарбоксиоксими
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG37836A3 (bg) Метод за получаване на 4-хинолинови производни
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG31492A3 (bg) Метод за получаване на фенетаноламини
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG31498A3 (en) Method for obtaining of pyridiliminomethyl benzene derivatives
BG29870A3 (en) Method for obtaining of pyridon compounds
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG36495A3 (bg) Метод за получаване на 4-хинолови производни
BG32117A4 (bg) Метод за получаване олеандомицини
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG35749A3 (bg) Метод за получаване на 20-дихидро-20,23-дидеокситидонолид
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG35032A3 (bg) Метод за получаване на 1, 1, 2- трифенилпропенови производни
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG35037A3 (en) Method for preparing phenylaminic derivatives
BG34454A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина